A relaxin-based nanotherapy for liver fibrosis. (2021)
Attributed to:
The Role of Tissue-resident Hepatic Macrophages in the Resolution of Chronic Liver Injury
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41565-020-00832-w
PubMed Identifier: 33495619
Publication URI: http://europepmc.org/abstract/MED/33495619
Type: Journal Article/Review
Volume: 16
Parent Publication: Nature nanotechnology
Issue: 4
ISSN: 1748-3387